![Pyrazolo[1,5-a]pyrimidine-3-carboxamide, N-[3-(difluoromethyl)-1-[trans-4-[[4-[[3-[1-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-methyl-2-oxo-1H-benzimidazol-4-yl]-2-propyn-1-yl]oxy]-1-piperidinyl]methyl]cyclohexyl]-1H-pyrazol-4-yl]-5-(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl- structure, CAS 2432994-31-3](/structures/210000/202291_1_2432994_31_3.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2432994-31-3 |
| Catalog No. | 2A-0200374 |
| Chinese Name | PROTAC IRAK4 degrader-7 |
| Molecular Formula | C44H49O6N11F2 |
| Molecular Weight | 865.94 |
| Application | PROTAC IRAK4 degrader-7 (compound I-417) is an orally active PROTAC-IRAK4 degrader with anti-tumor activity [1]. |
| MDL Number | MFCD35054646 |
| MSDS | msds/202291_1_2432994_31_3.pdf |
| Transport Info | Product name: PROTAC IRAK4 degrader-7 |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA